title: Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology.
abstract: BACKGROUND
  The management of background corticosteroid therapy in rheumatology clinical trials poses a major challenge. We describe the consensus methodology used to design an algorithm to standardize changes in corticosteroid dosing during the Randomized Placebo Phase Study of Rilonacept in Systemic Juvenile Idiopathic Arthritis Trial (RAPPORT).
  
  
  METHODS
  The 20 RAPPORT site principal investigators (PIs) and 4 topic specialists constituted an expert panel that participated in the consensus process. The panel used a modified Delphi Method consisting of an on-line questionnaire, followed by a one day face-to-face consensus conference. Consensus was defined as ≥ 75% agreement. For items deemed essential but when consensus on critical values was not achieved, simple majority vote drove the final decision.
  
  
  RESULTS
  The panel identified criteria for initiating or increasing corticosteroids. These included the presence or development of anemia, myocarditis, pericarditis, pleuritis, peritonitis, and either complete or incomplete macrophage activation syndrome (MAS). The panel also identified criteria for tapering corticosteroids which included absence of fever for ≥ 3 days in the previous week, absence of poor physical functioning, and seven laboratory criteria. A tapering schedule was also defined.
  
  
  CONCLUSIONS
  The expert panel established consensus regarding corticosteroid management and an algorithm for steroid dosing that was well accepted and used by RAPPORT investigators. Developed specifically for the RAPPORT trial, further study of the algorithm is needed before recommendation for more general clinical use.
authors.affiliation: Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA. nilowite@montefiore.org.
authors.forename: Norman T
authors.initials: NT
authors.lastname: Ilowite
authors.forename: Christy I
authors.initials: CI
authors.lastname: Sandborg
authors.forename: Brian M
authors.initials: BM
authors.lastname: Feldman
authors.forename: Alexi
authors.initials: A
authors.lastname: Grom
authors.forename: Laura E
authors.initials: LE
authors.lastname: Schanberg
authors.forename: Edward H
authors.initials: EH
authors.lastname: Giannini
authors.forename: Carol A
authors.initials: CA
authors.lastname: Wallace
authors.forename: Rayfel
authors.initials: R
authors.lastname: Schneider
authors.forename: Kathleen
authors.initials: K
authors.lastname: Kenney
authors.forename: Beth
authors.initials: B
authors.lastname: Gottlieb
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Hashkes
authors.forename: Lisa
authors.initials: L
authors.lastname: Imundo
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Kimura
authors.forename: Bianca
authors.initials: B
authors.lastname: Lang
authors.forename: Michael
authors.initials: M
authors.lastname: Miller
authors.forename: Diana
authors.initials: D
authors.lastname: Milojevic
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: O'Neil
authors.forename: Marilynn
authors.initials: M
authors.lastname: Punaro
authors.forename: Natasha
authors.initials: N
authors.lastname: Ruth
authors.forename: Nora G
authors.initials: NG
authors.lastname: Singer
authors.forename: Richard K
authors.initials: RK
authors.lastname: Vehe
authors.forename: James
authors.initials: J
authors.lastname: Verbsky
authors.forename: Amy
authors.initials: A
authors.lastname: Woodward
authors.forename: Lawrence
authors.initials: L
authors.lastname: Zemel